Each month, we screen the Europe-listed stocks under Morningstar’s coverage for newly undervalued names.
Over the past month, one stock saw its Morningstar Rating change to 4 stars, while another one dropped into 5-star territory. Stocks rated 3 stars are fairly valued according to Morningstar analysts, while those rated 1 or 2 stars are considered overvalued.
The one new 4-star European stock is:
· Leonardo LDO
The one new 5-star European stock is:
· Coloplast COLO B
All returns in this article are reported in the stock’s base currency and all data is sourced from Morningstar Direct.
Newly Undervalued Stocks as of May 12
The Morningstar Europe Index rose 12.82% over the past month, leaving the overall European stock market slightly undervalued, hovering at a 4% discount to its fair value estimate on a cap-weighted basis.
Of the 298 Europe-listed stocks covered by Morningstar analysts:
· 45% are undervalued, 35% are fairly valued, and 21% are overvalued.
· One is newly undervalued.
· 36 are newly overvalued.
· One moved from a 4-star rating to a 5-star rating.
· 29 moved from a 5-star rating to a 4-star rating.
· Among the newly undervalued stocks, none jumped from a 3-star rating to a 5-star rating.
· 61 are no longer undervalued.
Morningstar analysts assign every stock under their coverage a fair value estimate, which is an intrinsic measure of the stock’s worth, and an Uncertainty Rating, which captures the range of potential outcomes for that estimate. A higher Uncertainty Rating equates to a larger range of prices considered fairly valued.
These two metrics and the stock’s current price, are used to determine its Morningstar Rating.
Distribution of Star Ratings for Europe-Listed Stocks
Source: Morningstar Direct. Data as of May 12, 2025.
Metrics for this Month’s New 4-Star Stock
Leonardo LDO
- Morningstar Rating: ★★★★
- One-Month Return: 6.53%
Aerospace and defense company Leonardo is up 51.59% over the past three months and 101.71% over the past year. The fair value estimate for Leonardo rose to EUR 62.60 from EUR 42.40 during the month. It ended the month trading at a 28% discount to its new fair value estimate, with an Uncertainty Rating of High. The large-growth stock has a narrow economic moat.
Metrics for this Month’s New 5-Star Stock
Coloplast COLO B
- Morningstar Rating: ★★★★★
- One-Month Return: -7.50%
Medical supplies company Coloplast is down 18.96% over the past three months and 21.84% over the past year. The stock’s price is 34% below its fair value estimate of DKK 962, with an Uncertainty Rating of Medium. The large-growth stock has a wide economic moat.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.